mail
versión imprimible
 
 

3rd ALS Drug Development Summit 2024

Evvnt Promotion / evvnt
-
21.05.2024 - 23.05.2024  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temas de la conferencia
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals

Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2215799-3?pid=4832

Speakers: Diego Cadavid Chief Medical Officer Verge Genomics, Disha Sood Senior Scientist Sanofi , Emily Caporello Director, Small Business Program NINDS/NIH , and more
 

Información e inscripción:

https://go.evvnt.com/2215799-2?pid=4832
Ms. Erin Thomas
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Industry Pricing - Conference + Workshop Day: USD 3597.00, Industry Pricing - Conference Only: USD 2599.00, Service Provider Pricing - Conference + Workshop Day: USD 5197.00, Service Provider Pricing - Conference Only: USD 3699.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.Charité International AcademyAlumni Club Medizinische Universität WienCenter of ExcellenceÖsterreichische Gesellschaft für Public HealthHilfswerk AustriaÖsterreichische Akademie der Ärzte